Sanofi: all 2,424 studies
Page 14 of 25. Open to participants first (105), then studies with results posted, then the rest; newest registration first within each.
- DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed InfantsCompletedNCT02094833Phase 3
- Capecitabine Plus Aflibercept as Maintenance Therapy Following Capecitabine Plus Oxaliplatin Plus Aflibercept in Patients With Metastatic Colorectal CancerWithdrawnNCT02085005Phase 2
- Efficacy of a Chronic Care Model Supported by Self Monitoring of Blood Glucose With BGStar Over Usual Care in Improving Glycemic Control in Patients With Type 2 Diabetes Not Treated With InsulinCompletedNCT02082028Not applicable
- A Comparative Study to Evaluate Two Air-Activated Adhesive Backed Heat PatchesTerminatedNCT02080143Not applicable
- Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate CancerCompletedNCT02074137Phase 4
- Comparative Study of a Smartphone-Linked Self-Monitoring System Versus a Traditional One for Improving Metabolic Control and Compliance to Self-Monitoring of Blood GlucoseCompletedNCT02073188Phase 3
- A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1BActive, not recruitingNCT02065011Phase 2
- Study to Evaluate the Response Rate to Therapy With Docetaxel and Cisplatin in Unresectable Locally Advanced Squamous Cell Carcinoma of Head and NeckCompletedNCT02061631Phase 2
- A Study to Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese VolunteersCompletedNCT02046629Phase 1
- Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated PoliomyelitisCompletedNCT02040636Phase 2
- A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B PatientsCompletedNCT02035605Phase 1
- Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor TherapyCompletedNCT02027753Phase 4
- Sarilumab Effect on the Pharmacokinetics of SimvastatinCompletedNCT02017639Phase 1
- Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXACompletedNCT02012998Phase 3
- Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A Vaccine) in Toddlers, Children and AdolescentsCompletedNCT02011763Phase 4
- A Study of the Immune Response to Heplisav in Healthy Older AdultsCompletedNCT01999699Phase 1
- Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China.CompletedNCT01993173Phase 3
- A Safety and Efficacy Study of SAR405838 and Pimasertib in Cancer PatientsCompletedNCT01985191Phase 1
- Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa VaccinationCompletedNCT01983540Phase 3
- Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 DiabetesCompletedNCT01960179Phase 3
- Effect of Alirocumab on Lipid Metabolism in Adults With Elevated LDL-CholesterolCompletedNCT01959971Phase 1
- A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the PhilippinesCompletedNCT01949675Phase 4
- Observational Study to Evaluate Vandetanib in RET -/+ Patients With Metastatic Medullary Thyroid CancerCompletedNCT01945762
- Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy RegistryCompletedNCT01945424
- A Study of the Safety and Pharmacokinetics of SAR245408 Tablets in Patients With Solid Tumors or LymphomaCompletedNCT01943838Phase 1
- Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 DiabetesCompletedNCT01940965Phase 3
- A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid MalignanciesCompletedNCT01930552Phase 1
- Purified Vero Rabies Vaccine-Serum Free Compared to Human Diploid Cell Vaccine in a Pre-exposure Prophylaxis RegimenCompletedNCT01930357Phase 2
- ALX-0171 Safety Study in Adults With Hyperresponsive AirwaysCompletedNCT01909843Phase 1
- Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel in Patients With Advanced Solid TumorsCompletedNCT01907685Phase 1
- Safety and Efficacy Evaluation of Repeat neoGAA Dosing in Late Onset Pompe Disease Patients.CompletedNCT01898364Phase 1
- Study of a Candidate Clostridium Difficile Toxoid Vaccine in Healthy Adult Subjects Aged 40 to 75 Years in JapanCompletedNCT01896830Phase 1/2
- Study of Purified Vero Rabies Vaccine and Rabies Human Diploid Cell Vaccine in a Simulated Rabies Post-exposure RegimenCompletedNCT01877395Phase 2
- ALX-0171 Phase I Pharmacokinetic Study in Healthy Male VolunteersCompletedNCT01875926Phase 1
- Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple SclerosisCompletedNCT01863888Phase 3
- Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)TerminatedNCT01861249Phase 2
- Post Authorisation Safety Study of Renvela® in Chronic Kidney Disease Patients Not on Dialysis With HyperphosphataemiaCompletedNCT01857024
- Single Ascending Dose Study of Safety and Tolerability of Sarilumab and Methotrexate in Japanese Patients With Rheumatoid ArthritisCompletedNCT01850680Phase 1
- Cumulative Irritation Patch TestCompletedNCT01842711
- Evaluation of Experimental and Commercial Air-Activated, Adhesive Backed Heat PatchesCompletedNCT01841801Not applicable
- Evaluation of Experimental Heat PatchCompletedNCT01841788Not applicable
- A Study of Renal Function in Treatment-naïve, Young Male Patients With Fabry DiseaseTerminatedNCT01839526Phase 1
- Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster VaccinationCompletedNCT01839175Phase 3
- Euglycemic Clamp Study Comparing Two New Insulin Glargine Formulations in Subjects With Type 1 Diabetes MellitusCompletedNCT01838083Phase 1
- Regulatory Post-Marketing Surveillance Study for Hepatitis A Vaccine (AVAXIM 160U)CompletedNCT01838070
- Effectiveness and Safety of Amisulpride in Chinese Patients With SchizophreniaCompletedNCT01795183Phase 4
- Pharmacokinetic of Alirocumab SAR236553 (REGN727) Administered Subcutaneously at 3 Different Injection Sites in Healthy SubjectsCompletedNCT01785329Phase 1
- Comparison of Purified Vero Rabies Vaccine, Serum Free With Human Diploid Cell Vaccine in Pre-exposure UseCompletedNCT01784874Phase 2
- Evaluation of Plerixafor Plus G-CSF to Mobilize and Collect 5×10^6CD34+ Cells/kg in Non-Hodgkin's Lymphoma (NHL) Patients for Autologous TransplantationCompletedNCT01767714Phase 3
- Vandetanib Risk Minimisation EffectivenessCompletedNCT01757470
- A Dose Finding Study of XRP6258 in Patients With Advanced Solid TumorsCompletedNCT01755390Phase 1
- An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem CellsCompletedNCT01753453Phase 2
- SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM PatientsCompletedNCT01749969Phase 1
- Registry of Patients Treated With Plerixafor (Mozobil®) for Haematopoietic Stem Cell Mobilization Before Autologous TransplantationCompletedNCT01738373
- Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular DegenerationActive, not recruitingNCT01736592Phase 2
- A Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 TumoursCompletedNCT01736163
- Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on HemodialysisCompletedNCT01736150Phase 3
- Pharmacokinetic Profile and Pharmacodynamic Characteristics of a Furosemide High Dosage Formulation in Patients With Chronic Renal Failure Undergoing Peritoneal DialysisCompletedNCT01724788Phase 1
- Effect of Alirocumab (SAR236553/REGN727) Administered on Top of Ezetimibe or Fenofibrate on Lipid Profiles in Healthy SubjectsCompletedNCT01723735Phase 1
- Tolerability and Safety Study of Recombinant Human Acid Sphingomyelinase in Acid Sphingomyelinase Deficiency PatientsCompletedNCT01722526Phase 1
- A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of Genz-682452 in Healthy VolunteersCompletedNCT01710826Phase 1
- Alglucosidase Alfa Pompe Safety Sub-RegistryCompletedNCT01710813
- Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately ControlledCompletedNCT01699932Phase 3
- Interaction Study to Assess the Pharmacokinetic Interaction of Oral Administration of Rifapentine on ATRIPLA™ in HIV PatientsCompletedNCT01690403Phase 1
- Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes MellitusCompletedNCT01689142Phase 3
- Comparison of a New Formulation of Insulin Glargine With Lantus® in Japanese Patients With Type 1 Diabetes MellitusCompletedNCT01689129Phase 3
- Repeated Dose Study With a New Insulin Glargine Formulation and Lantus® on 24-hour Glucose Profile in Japanese Patients With Type 1 Diabetes MellitusCompletedNCT01676233Phase 1
- Safety, Tolerability and Pharmacokinetics of Genz-682452 in Healthy MenCompletedNCT01674036Phase 1
- A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced CancerCompletedNCT01673737Phase 1
- Pharmacokinetic and Tolerability of Alirocumab SAR236553 (REGN727) in Patients With Hepatic Impairment and in Healthy SubjectsCompletedNCT01670734Phase 1
- A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS)CompletedNCT01665391Phase 2
- Study to Evaluate the Effect of Eliglustat on the Pharmacokinetics, Safety and Tolerability of Metoprolol in Healthy AdultsCompletedNCT01659944Phase 1
- Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative ColitisTerminatedNCT01659138Phase 2
- Phase I, Dose Escalation of SAR125844 in Asian Solid Tumor PatientsCompletedNCT01657214Phase 1
- Proof of Biological Activity of SAR100842 in Systemic SclerosisCompletedNCT01651143Phase 2
- Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate CancerCompletedNCT01649635Phase 4
- Phase 1 Safety Testing of SAR405838CompletedNCT01636479Phase 1
- Assessment of the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin +/- MetforminCompletedNCT01632163Phase 3
- Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 DiabetesCompletedNCT01630369Phase 4
- Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine MonotherapyCompletedNCT01625494Phase 3
- Immunogenicity and Safety of Verorab® in a "One-week" Intradermal Post-exposure Prophylaxis RegimenCompletedNCT01622062Phase 3
- Evaluation of the Potential Effects of SSR149415 on the Hypothalamic-pituitary-adrenal Axis in Outpatients With Major Depressive DisorderCompletedNCT01606384Phase 2
- Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part IICompletedNCT01598415Phase 2
- A Study of the Safety and Pharmacokinetics of SAR245409 Tablets in Patients With Solid Tumors or LymphomaCompletedNCT01596270Phase 1
- Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical TrialCompletedNCT01593228Phase 3
- Post Authorisation Safety Study of Triaxis as a 5th Dose in 4-6 Year Old Spanish ChildrenCompletedNCT01583049
- A Phase I Dose Escalation Study of Plerixafor in Healthy Subjects of Japanese DescentCompletedNCT01579149Phase 1
- Continued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate CancerCompletedNCT01576029Phase 2
- Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 DiabetesCompletedNCT01572649Phase 1
- Study of AVE5026 at Weight-adjusted Doses in Children With a Central Venous LineTerminatedNCT01567904Phase 2
- Study in Healthy Volunteers to Assess the Pharmacokinetics (PK) of Digoxin Administered Alone and in Combination With VandetanibCompletedNCT01561781Phase 1
- A Phase I Study to Assess the Pharmacokinetics of Metformin When Administered Alone and in Combination With VandetanibCompletedNCT01551615Phase 1
- Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin LesionCompletedNCT01551069Phase 3
- Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRECompletedNCT01546909Phase 4
- Study in Healthy Volunteers to Assess the Pharmacokinetics of Midazolam Administered Alone and in Combination With VandetanibCompletedNCT01544140Phase 1
- Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of VandetanibCompletedNCT01539655Phase 1
- Safety, Tolerability and Pharmacokinetics of SAR231893 (REGN668) in Healthy Japanese Adult Male SubjectsCompletedNCT01537653Phase 1
- Comparison of the Pharmacokinetics and Safety of Two SAR231893 (REGN668) Drug Products in Healthy SubjectsCompletedNCT01537640Phase 1
- To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT01529853Phase 1/2
- Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal ImpairmentCompletedNCT01527929Phase 1